• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

平均血小板体积作为非酒精性脂肪性肝病患者肝纤维化的生物标志物

Mean platelet volume as a biomarker for liver fibrosis in patients with Non-alcoholic fatty liver disease.

作者信息

Cho Eun Hye, Kim Jee Ah, Park Min-Seung, Kwon Min-Jung, Park Hyosoon, Woo Hee-Yeon

机构信息

Department of Laboratory Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.

出版信息

PLoS One. 2025 Feb 18;20(2):e0318847. doi: 10.1371/journal.pone.0318847. eCollection 2025.

DOI:10.1371/journal.pone.0318847
PMID:39964985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11835247/
Abstract

INTRODUCTION

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent cause of chronic liver disease worldwide. Accurate assessment of liver fibrosis is essential for the prognosis and management of NAFLD. Mean platelet volume (MPV), an index of platelet activation, has been associated with liver fibrosis in various chronic liver diseases; however, its role in NAFLD remains uncertain.

METHODS

This study analyzed data from 70,830 patients with NAFLD who underwent a comprehensive health examination between 2015 and 2019. Patients were stratified into three groups based on the fibrosis-4 (FIB-4) index: low (<1.30), indeterminate (1.30-2.67), and high (>2.67). We evaluated the differences in MPV among these groups and analyzed the association between MPV and the FIB-4 index.

RESULTS

MPV varied significantly across the three groups categorized by the FIB-4 index (p < 0.001). Additionally, a weak but statistically significant positive correlation was observed between MPV and the FIB-4 index (rho =  0.170, p <  0.001). Multivariable linear regression adjusted for multiple covariates showed that MPV remained significantly associated with the FIB-4 index (β =  0.01, p <  0.001).

CONCLUSIONS

MPV may serve as a supplementary non-invasive marker for assessing liver fibrosis in patients with NAFLD. Further studies are required to validate these findings and explore the utility of MPV in conjunction with other non-invasive markers.

摘要

引言

非酒精性脂肪性肝病(NAFLD)是全球慢性肝病最常见的病因。准确评估肝纤维化对于NAFLD的预后和管理至关重要。平均血小板体积(MPV)是血小板活化的一个指标,在各种慢性肝病中已被证明与肝纤维化有关;然而,其在NAFLD中的作用仍不明确。

方法

本研究分析了2015年至2019年间接受全面健康检查的70830例NAFLD患者的数据。根据纤维化-4(FIB-4)指数将患者分为三组:低(<1.30)、不确定(1.30-2.67)和高(>2.67)。我们评估了这些组之间MPV的差异,并分析了MPV与FIB-4指数之间的关联。

结果

根据FIB-4指数分类的三组患者的MPV有显著差异(p<0.001)。此外,MPV与FIB-4指数之间存在微弱但具有统计学意义的正相关(rho = 0.170,p < 0.001)。对多个协变量进行调整的多变量线性回归显示,MPV与FIB-4指数仍有显著关联(β = 0.01,p < 0.001)。

结论

MPV可作为评估NAFLD患者肝纤维化的一种补充性非侵入性标志物。需要进一步的研究来验证这些发现,并探索MPV与其他非侵入性标志物联合使用的效用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c89d/11835247/19dd53fb0769/pone.0318847.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c89d/11835247/19dd53fb0769/pone.0318847.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c89d/11835247/19dd53fb0769/pone.0318847.g001.jpg

相似文献

1
Mean platelet volume as a biomarker for liver fibrosis in patients with Non-alcoholic fatty liver disease.平均血小板体积作为非酒精性脂肪性肝病患者肝纤维化的生物标志物
PLoS One. 2025 Feb 18;20(2):e0318847. doi: 10.1371/journal.pone.0318847. eCollection 2025.
2
A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients: multicentric study.一种以平均血小板体积和中性粒细胞与淋巴细胞比值作为非酒精性脂肪性肝病(NAFLD)患者非酒精性脂肪性肝炎标志物的新型模型:多中心研究。
Eur J Gastroenterol Hepatol. 2016 Jan;28(1):e1-9. doi: 10.1097/MEG.0000000000000486.
3
Plateletcrit and Mean Platelet Volume in the Evaluation of Alcoholic Liver Cirrhosis and Nonalcoholic Fatty Liver Disease Patients.血小板压积和平均血小板体积在评估酒精性肝硬化和非酒精性脂肪性肝病患者中的应用。
Biomed Res Int. 2021 Feb 15;2021:8867985. doi: 10.1155/2021/8867985. eCollection 2021.
4
Distribution of liver stiffness in non-alcoholic fatty liver disease with higher fibrosis-4 index than low cut-off index.肝纤维化 4 指数高于低截断指数的非酒精性脂肪性肝病患者的肝硬度分布。
J Gastroenterol Hepatol. 2019 Aug;34(8):1411-1416. doi: 10.1111/jgh.14559. Epub 2019 Jan 6.
5
Is mean platelet volume a simple marker of non-alcoholic fatty liver disease?平均血小板体积是简单的非酒精性脂肪肝标志物吗?
Indian J Gastroenterol. 2023 Apr;42(2):219-225. doi: 10.1007/s12664-022-01330-8. Epub 2023 Apr 27.
6
The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease.γ-谷氨酰转肽酶与血小板比值用于慢性乙型肝炎和非酒精性脂肪性肝病患者肝纤维化的无创评估
Oncotarget. 2017 Apr 25;8(17):28641-28649. doi: 10.18632/oncotarget.16162.
7
Assessing the consistency of FIB-4, APRI, and GPR in evaluating significant liver fibrosis and cirrhosis in COVID-19 patients with concurrent liver diseases.评估FIB-4、APRI和GPR在评估合并肝脏疾病的COVID-19患者显著肝纤维化和肝硬化中的一致性。
BMC Gastroenterol. 2025 Mar 20;25(1):191. doi: 10.1186/s12876-025-03770-w.
8
Diagnostic Accuracy of Platelet Count and Platelet Indices in Noninvasive Assessment of Fibrosis in Nonalcoholic Fatty Liver Disease Patients.血小板计数和血小板指数在非酒精性脂肪性肝病患者肝纤维化无创评估中的诊断准确性。
Can J Gastroenterol Hepatol. 2017;2017:6070135. doi: 10.1155/2017/6070135. Epub 2017 Dec 31.
9
Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.在退伍军人健康管理局中识别非酒精性脂肪性肝病的肝纤维化程度。
Dig Dis Sci. 2018 Sep;63(9):2259-2266. doi: 10.1007/s10620-018-5123-3. Epub 2018 May 19.
10
The diagnostic utility of FIB-4 as a non-invasive tool for liver fibrosis scoring among NAFLD patients: a retrospective cross-sectional study.FIB-4 作为一种非侵入性工具在非酒精性脂肪性肝病患者肝纤维化评分中的诊断效用:一项回顾性横断面研究。
Eur Rev Med Pharmacol Sci. 2024 Apr;28(8):3104-3111. doi: 10.26355/eurrev_202404_36026.

引用本文的文献

1
Correlation between PLT, MPV, PDW and liver fibrosis and inflammatory activity in patients with NAFLD: A retrospective case-control study.非酒精性脂肪性肝病患者血小板计数(PLT)、平均血小板体积(MPV)、血小板分布宽度(PDW)与肝纤维化及炎症活动的相关性:一项回顾性病例对照研究
Medicine (Baltimore). 2025 Aug 15;104(33):e43815. doi: 10.1097/MD.0000000000043815.

本文引用的文献

1
Potential role of Fibrosis-4 score in hepatocellular carcinoma screening: The Kangbuk Samsung Health Study.
Hepatol Res. 2024 Jun;54(6):551-561. doi: 10.1111/hepr.13999. Epub 2024 Jan 6.
2
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review.非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)的全球流行病学:系统评价。
Hepatology. 2023 Apr 1;77(4):1335-1347. doi: 10.1097/HEP.0000000000000004. Epub 2023 Jan 3.
3
Chronic Inflammation-A Link between Nonalcoholic Fatty Liver Disease (NAFLD) and Dysfunctional Adipose Tissue.慢性炎症——非酒精性脂肪性肝病(NAFLD)与功能障碍性脂肪组织之间的联系。
Medicina (Kaunas). 2022 May 6;58(5):641. doi: 10.3390/medicina58050641.
4
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets.非酒精性脂肪性肝病 (NAFLD) 的严重程度与血小板的非止血贡献和促炎表型有关。
Transl Res. 2021 May;231:24-38. doi: 10.1016/j.trsl.2020.11.003. Epub 2020 Nov 7.
5
Evaluation of the diagnostic validity of noninvasive tests for predicting liver fibrosis stage in chronic hepatitis B patients.评估慢性乙型肝炎患者肝纤维化分期预测中无创检测的诊断效度。
Acta Gastroenterol Belg. 2020 Jul-Sep;83(3):419-425.
6
Non-alcoholic fatty liver disease: a multidisciplinary approach towards a cardiometabolic liver disease.非酒精性脂肪性肝病:一种针对心肝代谢疾病的多学科方法。
Eur J Endocrinol. 2020 Sep;183(3):R57-R73. doi: 10.1530/EJE-20-0065.
7
Large and small platelets-(When) do they differ?大血小板与小血小板——它们何时存在差异?
J Thromb Haemost. 2020 Jun;18(6):1256-1267. doi: 10.1111/jth.14788. Epub 2020 Apr 9.
8
Platelet indices significantly correlate with liver fibrosis in HCV-infected patients.血小板指标与 HCV 感染患者的肝纤维化显著相关。
PLoS One. 2020 Jan 9;15(1):e0227544. doi: 10.1371/journal.pone.0227544. eCollection 2020.
9
Platelet TGF-β1 deficiency decreases liver fibrosis in a mouse model of liver injury.血小板转化生长因子-β1 缺乏可减少肝损伤小鼠模型中的肝纤维化。
Blood Adv. 2018 Mar 13;2(5):470-480. doi: 10.1182/bloodadvances.2017010868.
10
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的临床流行病学和疾病负担。
World J Gastroenterol. 2017 Dec 21;23(47):8263-8276. doi: 10.3748/wjg.v23.i47.8263.